Digital disruption set to revolutionise regional healthcare landscape by 2050

charles-goddard

– Over the past six years, cancer incidence throughout the UAE has almost doubled. By 2030, it is due to rise faster in the Middle East than any other region in the world
– Global healthcare professionals will address innovative solutions in regional healthcare at The Economist’s inaugural War on Cancer Middle East event

At The Economist’s inaugural War on Cancer Middle East event next week, global healthcare professionals will address the enormous regional and global challenge presented by rising cancer prevalence, which is set to rise faster in the Middle East than any other region by 2030.

The one-day event, hosted by The Economist Group, aims to explore the state of cancer prevention, diagnosis and care throughout the Middle East and address issues such as poor healthcare access and late presentation.
In a series of robust panel debates, strategy sessions and key note interviews, representatives from the healthcare industry, government and academics will tackle regional challenges, which include limited data on cancer incidence, mortality and patient satisfaction.

The forum is set to be attended by leading pharmaceutical companies, government officials and business leaders, with panel sessions including ‘Middle East 2050,’ looking ahead to innovation that could revolutionise cancer care in the region over the coming decades,. Richard Sullivan, a professor of cancer and global health at Kings College London and Vivek Muthu, chief health adviser The Economist Intelligence Unit will tackle this issue in a one-on-one interview.

“We believe that bringing the global War on Cancer conference to the region will provide a platform for the healthcare industry to converge, recognise and discuss various innovative solutions for addressing the increasing incidence of the disease throughout Middle East,” said Charles Goddard, editorial director, Asia-Pacific, The Economist Intelligence Unit, and chair of the event.

There will also be interviews with patients throughout the day, in order to ensure that their perspective remains at the front and centre of the day’s debate. .Early Detection and Screening will address the acute challenge of late detection in the Middle East, which decreases the likelihood of survival.

Sponsors nclude Roche, PhRMA, PhRMAG, AstraZeneca, Pfizer, Novartis and Johns Hopkins Medicine International.

In 2015 The Economist Events declared war on cancer at an inaugural summit in London. Since then, the conversation has been taken from Boston to Hong Kong, and Singapore to Oslo, to explore the most pressing issues in policy and financing, treatment and care across the globe. Bringing together a diverse audience from the policy, finance, and medical communities, the aim has been to share best practice and to catalyse action; breaking down silos to confront the enormous challenge cancer that presents.

For details of the War On Cancer Middle East event being held on May 1st 2018 at the Taj Hotel, Business Bay, visit:
https://events.economist.com/events-conferences/emea/war-on-cancer-middle-east

**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.

Related Articles